These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 802852)

  • 21. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukocyte migration inhibition with spleen extracts and other antigens in patients with renal allografts.
    Dormont J; Sobel A; Galanaud P; Crevon MC; Colombani J
    Transplant Proc; 1972 Jun; 4(2):265-9. PubMed ID: 4113699
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB; Ladefoged SD; Larsen S
    APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The detection and evaluation of migration stimulatory factor in renal allograft recipients.
    Cerilli J; Fesperman DP
    Surgery; 1976 Jul; 80(1):92-7. PubMed ID: 775669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunological problems in renal transplants].
    Pytel' AIa; Riabinskiĭ VS
    Urol Nefrol (Mosk); 1974; 32(3):54-69. PubMed ID: 4155547
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies in cellular immunity. Wrinkles in the models.
    Taguchi Y; Siddiquie N; Shepard RR; MacKinnon KJ
    Invest Urol; 1972 Jul; 10(1):96-101. PubMed ID: 4402589
    [No Abstract]   [Full Text] [Related]  

  • 31. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crossmatch with donor skin: its correlation with early rejection of kidney transplants.
    Lasmar E; Távora E; Salomão A; Bambirra E; Penafiel P; Vilaça S
    Transplant Proc; 1992 Dec; 24(6):3070-1. PubMed ID: 1466059
    [No Abstract]   [Full Text] [Related]  

  • 33. Cellular immune response against human red blood cell antigens and renal allograft rejection.
    Ishibashi M; Kokado Y; Takahara S; Ichikawa Y; Sonoda T
    Transplant Proc; 1987 Dec; 19(6):4511-5. PubMed ID: 3321609
    [No Abstract]   [Full Text] [Related]  

  • 34. Cellular immunity to a purified kidney antigen assessed by macrophage migratory inhibition and MIF release by human leukocytes.
    Melnick HD; Friedman H
    Transplant Proc; 1971 Mar; 3(1):465-9. PubMed ID: 4106327
    [No Abstract]   [Full Text] [Related]  

  • 35. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular and humoral immunity after clinical renal transplantation.
    Arnesen E; Bondevik H; Thorsby E
    Proc Eur Dial Transplant Assoc; 1975; 11():343-50. PubMed ID: 1105555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictive value of measurement of cell-mediated immunity on outcome of renal transplantation.
    Hamilton DN; Briggs JD; Watson MA; Dick HM; Bradley JA
    Transplant Proc; 1981 Sep; 13(3):1561-2. PubMed ID: 7029814
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA regulates postrenal transplant CML nonreactivity.
    Goulmy E; Blokland E; Persijn G; Paul LC; Wilmink J; van Rood JJ
    J Immunol; 1985 Nov; 135(5):3082-6. PubMed ID: 3900203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histocompatibility in humans.
    Fotino M
    Ann Clin Lab Sci (1971); 1971; 1(2):125-30. PubMed ID: 4405210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.